STAGE IVA OVARIAN CANCER AJCC V8
Clinical trials for STAGE IVA OVARIAN CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA OVARIAN CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA OVARIAN CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug combo targets recurrent gynecologic cancers
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib combined with radiation therapy for people whose gynecologic cancer (like ovarian, uterine, or cervical) has returned. The goal is to find the safest dose and see if the combination can shrink tumors. About 24 participants wi…
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New drug combo trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will take …
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:51 UTC
-
Chemo mist trial aims to shrink abdominal tumors with fewer side effects
Disease control Recruiting nowThis early-phase trial is testing a procedure called PIPAC, which turns liquid chemotherapy into a fine mist and sprays it directly into the abdomen during a keyhole surgery. It is for people with ovarian, uterine, appendix, colorectal, or stomach cancer that has spread to the li…
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 03:47 UTC
-
Less invasive surgery may help ovarian cancer patients recover faster
Disease control Recruiting nowThis study tests if a less invasive surgery (laparoscopy) works as well as standard open surgery for people with advanced ovarian, fallopian tube, or peritoneal cancer who have already had chemotherapy. About 580 participants will be randomly assigned to one of the two surgeries.…
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:47 UTC
-
Electric field therapy worn like a vest shows promise against tough cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields to disrupt cancer cell growth, combined with standard drugs (cabozantinib or nab-paclitaxel plus atezolizumab). About 43 adults with advanced solid tumors in the abdomen or chest that have s…
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:47 UTC
-
Heated chemotherapy during surgery: a new hope for ovarian cancer patients?
Disease control Recruiting nowThis study looks at the safety of giving heated chemotherapy directly into the belly during surgery for advanced ovarian, fallopian tube, or peritoneal cancer. About 45 people will receive either chemotherapy before surgery or heated chemotherapy during surgery. The goal is to se…
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:36 UTC
-
Could a simple wash and blood test catch ovarian cancer sooner?
Diagnosis Recruiting nowThis study is testing a new way to detect ovarian cancer earlier by looking at DNA from a uterine wash and proteins in the blood. Researchers will collect samples from 250 women before surgery for a suspected ovarian mass or as a preventive measure for those with BRCA mutations. …
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated May 26, 2026 03:50 UTC